Leerink Swann began coverage on shares of Livongo Health (NASDAQ:LVGO) in a research report released on Monday, The Fly reports. The firm issued an outperform rating and a $50.00 price target on the stock.
Other equities research analysts have also recently issued reports about the company. Piper Jaffray Companies initiated coverage on Livongo Health in a report on Monday. They issued an overweight rating and a $40.00 price objective on the stock. Chardan Capital began coverage on shares of Livongo Health in a research note on Friday, August 16th. They issued a neutral rating and a $40.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $44.20.
LVGO stock opened at $34.95 on Monday. Livongo Health has a 12-month low of $31.60 and a 12-month high of $45.68.
Livongo Health Company Profile
Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.
Featured Article: Economic Bubble
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.